等待開盤 01-29 09:30:00 美东时间
-1.120
-2.35%
今日重点评级关注:Oppenheimer:维持Pelthos Therapeutics"跑赢大市"评级,目标价从57美元升至60美元;Small Cap Consumer Research:维持Lands' End"买入"评级,目标价从20美元升至45美元
01-27 10:02
Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price target from $53 to $58.
01-27 00:26
今日重点评级关注:Guggenheim:维持MBX Biosciences"买入"评级,目标价从77美元升至88美元;摩根士丹利:维持DraftKings"超配"评级,目标价从50美元升至53美元
01-20 10:26
Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $40 to $53.
01-17 02:27
Item 2.02 Results of Operations and Financial Condition. On January 12, 2026, during its scheduled presentation at the 44th Annual J.P. Morgan Healthcare Conference, Bruker Corporation (the "Company") stated that
01-13 01:05
Bruker BEST division announced $500M supply deals with global radiology companies for advanced superconductors used in MRI magnets.
01-09 22:34
The Bruker Energy & Supercon Technologies division, a segment of Bruker (BRKR), on Friday announced two multi-year supply agreements for Bruker’s latest superconductors, which are used by global radio...
01-09 20:25
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33
A U.S. appeals court has ruled against the Trump administration’s moves to implement drastic cuts to federal grant funding provided by the National Institutes of Health (NIH) to cover overhead costs i...
01-06 20:16